Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coordination Engineering of Ir─Mo Atomic Pair Sites to Break Scaling Limitations for Acidic Oxygen Evolution.

Angewandte Chemie (International ed. in English)·2026
Same author

Genetics of growth rate in induced pluripotent stem cells.

Stem cell reports·2026
Same author

Flow-Cell-Compatible Operando Surface-Enhanced Raman Spectroscopy for Probing Reaction Intermediates during Carbon Dioxide Reduction Reaction.

The journal of physical chemistry letters·2026
Same author

Hydrophobic Surface Modification Enables Tandem Ag/Cu Catalysis for CO<sub>2</sub> Electroreduction.

ACS applied materials & interfaces·2026
Same author

Exome sequencing and analysis of 44,028 British South Asians enriched for high autozygosity.

Nature genetics·2026
Same author

Under-Balcony Acoustic Diagnosis Using FOA-Based Directional Metrics: Early-Late Entropy and Vertical-Energy Discrepancy at 125 Hz, 1 kHz, and 4 kHz.

Sensors (Basel, Switzerland)·2026
Same journal

Covariance decomposition for distance based species tree estimation.

BMC bioinformatics·2026
Same journal

SNPio: a Python interface for population genomic data processing.

BMC bioinformatics·2026
Same journal

SpaHNR: a spatial domain identification method via sparse attention-based hierarchical node representation and multi-view contrastive learning.

BMC bioinformatics·2026
Same journal

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformatics·2026
Same journal

NAP: an open source pipeline for cross-domain microbiome profiling using Nanopore sequencing-derived amplicon data.

BMC bioinformatics·2026
Same journal

SurvGME: an R package for survival analysis with graphical and measurement error models.

BMC bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Mining Spatial Transcriptomics Datasets using DeepSpaceDB
10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

1.0K

MiningABs: mining associated biomarkers across multi-connected gene expression datasets.

Chun-Pei Cheng, Christopher DeBoever, Kelly A Frazer1

  • 1Department of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan. kafrazer@ucsd.edu.

BMC Bioinformatics
|June 10, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces MiningABs, a novel meta-analysis method to identify associated biomarkers (ABs) by considering gene combinations across microarray datasets. The approach effectively identifies cancer-related biomarkers for potential therapeutic development.

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K

Related Experiment Videos

Last Updated: Apr 28, 2026

Mining Spatial Transcriptomics Datasets using DeepSpaceDB
10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

1.0K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K

Area of Science:

  • Genomics
  • Bioinformatics
  • Biostatistics

Background:

  • Human diseases often result from alterations in gene sets, not individual genes.
  • Existing meta-analyses overlook gene interactions, focusing on independent biomarkers.
  • A new method is needed to analyze gene combinations across diverse microarray data.

Purpose of the Study:

  • To develop a meta-analysis method (MiningABs) for identifying associated biomarkers (ABs) considering gene combinations.
  • To enable the integration of data from different microarray platforms.
  • To improve the identification of disease-related biomarkers.

Main Methods:

  • Developed MiningABs, a meta-analysis approach using probe sequence similarity to link datasets.
  • Employed an improved common logit model (c-LM) with a genetic algorithm for AB identification.
  • Validated the method on esophageal squamous cell carcinoma and hepatocellular carcinoma datasets.

Main Results:

  • MiningABs successfully identified associated biomarkers (ABs) across different microarray datasets.
  • Each identified AB was crucial for accurate cancer sample classification.
  • ABs were found to be biologically relevant, strongly linked to cancer development and complex biological networks.

Conclusions:

  • The MiningABs method efficiently identifies associated biomarkers from diverse microarray data.
  • The identified ABs show strong relevance in cancer biology, confirmed by GO enrichment and network analyses.
  • Associated biomarkers hold potential for novel target and drug discovery, advancing cancer treatment.